Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-02
2006-05-02
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S443000, C514S469000
Reexamination Certificate
active
07037933
ABSTRACT:
The subject invention pertains to novel compounds (and salts thereof), and compositions comprising the compounds, for the treatment of cardiac arrhythmias. The subject invention further concerns methods of making the novel compounds. The novel compounds are rapidly metabolized analogs of amiodarone, having the distinct and advantageous characteristic of being metabolized to a less lipophilic compound. This results in an improved safety profile. The new compounds have particular utility for treating life-threatening ventricular tachyarrhythmias, especially in patients with congestive heart failure (CHF). The compounds also provide effective management for ventricular arrhythmias and supraventricular arrhythmias, including atrial fibrillation and re-entrant tachyarrhythmias involving accessory pathways.
REFERENCES:
patent: 5364880 (1994-11-01), Druzgala
ARYx Therapeutics, Inc.
McDonnell Boehnen & Hulbert & Berghoff LLP
Solola Taofiq
LandOfFree
Compounds for treatment of cardiac arrhythmia, synthesis,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds for treatment of cardiac arrhythmia, synthesis,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for treatment of cardiac arrhythmia, synthesis,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3642759